These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 16321379

  • 21. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
    Li Z, Prus AJ, Dai J, Meltzer HY.
    J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
    [Abstract] [Full Text] [Related]

  • 22. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P, Rakovska A, Zaekova G, Ballini C, Corte LD, Radomirov R, Vágvölgyi A.
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [Abstract] [Full Text] [Related]

  • 23. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
    Nakayama K, Sakurai T, Katsu H.
    Brain Res Bull; 2004 Apr 30; 63(3):237-41. PubMed ID: 15145142
    [Abstract] [Full Text] [Related]

  • 24. Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.
    Yamamura S, Ohoyama K, Hamaguchi T, Nakagawa M, Suzuki D, Matsumoto T, Motomura E, Tanii H, Shiroyama T, Okada M.
    Br J Pharmacol; 2009 Jun 30; 157(4):656-65. PubMed ID: 19371334
    [Abstract] [Full Text] [Related]

  • 25. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF, Segovia G, Mora F.
    Neurochem Int; 2008 Feb 30; 52(3):457-69. PubMed ID: 17881090
    [Abstract] [Full Text] [Related]

  • 26. A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
    Yamauchi M, Imanishi T, Koyama T.
    Neuropharmacology; 2012 Jun 30; 62(7):2278-87. PubMed ID: 22342987
    [Abstract] [Full Text] [Related]

  • 27. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
    Nagai T, Kitahara Y, Shiraki A, Hikita T, Taya S, Kaibuchi K, Yamada K.
    Neurosci Lett; 2010 Feb 12; 470(2):134-8. PubMed ID: 20045719
    [Abstract] [Full Text] [Related]

  • 28. Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex.
    Yoshino T, Nisijima K, Shioda K, Yui K, Katoh S.
    Neurosci Lett; 2004 Jun 24; 364(1):16-21. PubMed ID: 15193747
    [Abstract] [Full Text] [Related]

  • 29. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y, Boules M, Shaw AM, Williams K, Fredrickson P, Richelson E.
    Brain Res; 2008 Sep 22; 1231():6-15. PubMed ID: 18687313
    [Abstract] [Full Text] [Related]

  • 30. Differential increase of extracellular dopamine and serotonin in the 'prefrontal cortex' and striatum of pigeons during working memory.
    Karakuyu D, Herold C, Güntürkün O, Diekamp B.
    Eur J Neurosci; 2007 Oct 22; 26(8):2293-302. PubMed ID: 17908172
    [Abstract] [Full Text] [Related]

  • 31. Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex.
    Yoshino T, Nisijima K, Shioda K, Yui K, Kato S.
    Neurosci Lett; 2008 Jun 13; 438(1):67-9. PubMed ID: 18457919
    [Abstract] [Full Text] [Related]

  • 32. Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum.
    Westerink BH, Kawahara Y, De Boer P, Geels C, De Vries JB, Wikström HV, Van Kalkeren A, Van Vliet B, Kruse CG, Long SK.
    Eur J Pharmacol; 2001 Jan 26; 412(2):127-38. PubMed ID: 11165224
    [Abstract] [Full Text] [Related]

  • 33. Prenatal restraint stress: an in vivo microdialysis study on catecholamine release in the rat prefrontal cortex.
    Carboni E, Barros VG, Ibba M, Silvagni A, Mura C, Antonelli MC.
    Neuroscience; 2010 Jun 16; 168(1):156-66. PubMed ID: 20353810
    [Abstract] [Full Text] [Related]

  • 34. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.
    Kamińska K, Gołembiowska K, Rogóż Z.
    Pharmacol Rep; 2013 Jun 16; 65(5):1144-51. PubMed ID: 24399710
    [Abstract] [Full Text] [Related]

  • 35. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.
    Brain Res Bull; 2006 Mar 31; 69(2):204-13. PubMed ID: 16533671
    [Abstract] [Full Text] [Related]

  • 36. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM, Cathala A, Neny M, Rouge-Pont F, Drago F, Piazza PV, Spampinato U.
    J Neurochem; 2009 Oct 31; 111(2):614-23. PubMed ID: 19702657
    [Abstract] [Full Text] [Related]

  • 37. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
    Prus AJ, Huang M, Li Z, Dai J, Meltzer HY.
    Brain Res; 2007 Dec 12; 1184():354-64. PubMed ID: 17988654
    [Abstract] [Full Text] [Related]

  • 38. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F, Chalansonnet M, Carabin N, Micillino JC.
    Arch Toxicol; 2006 Oct 12; 80(10):703-12. PubMed ID: 16518643
    [Abstract] [Full Text] [Related]

  • 39. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 40. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
    Nair SG, Gudelsky GA.
    Brain Res Bull; 2006 Apr 28; 69(4):382-7. PubMed ID: 16624669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.